# The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients

> **NCT05944809** · PHASE2 · COMPLETED · sponsor: **JIANYANG WANG** · enrollment: 32 (actual)

## Conditions studied

- Esophageal Cancer
- Intensity-modulated Radiation Therapy
- Concurrent Chemoradiotherapy
- Thrombocytopenia

## Interventions

- **DRUG:** rhTPO

## Key facts

- **NCT ID:** NCT05944809
- **Lead sponsor:** JIANYANG WANG
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-20
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05944809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05944809, "The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05944809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*